Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

Alaa M Ali, Elena Provenzano, John MS Bartlett, Jean Abraham, Kristy Driver, Alison F Munro, Christopher Twelves, Christopher J Poole, Louise Hiller, Janet A Dunn, Helena M Earl, Carlos Caldas, Paul D Pharoah, None, Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. International Journal of Cancer. ,vol. 133, pp. 1470- 1478 ,(2013) , 10.1002/IJC.28150

Sohrab P Shah, Andrew Roth, Rodrigo Goya, Arusha Oloumi, Gavin Ha, Yongjun Zhao, Gulisa Turashvili, Jiarui Ding, Kane Tse, Gholamreza Haffari, Ali Bashashati, Leah M Prentice, Jaswinder Khattra, Angela Burleigh, Damian Yap, Virginie Bernard, Andrew McPherson, Karey Shumansky, Anamaria Crisan, Ryan Giuliany, Alireza Heravi-Moussavi, Jamie Rosner, Daniel Lai, Inanc Birol, Richard Varhol, Angela Tam, Noreen Dhalla, Thomas Zeng, Kevin Ma, Simon K Chan, Malachi Griffith, Annie Moradian, S-W Grace Cheng, Gregg B Morin, Peter Watson, Karen Gelmon, Stephen Chia, Suet-Feung Chin, Christina Curtis, Oscar M Rueda, Paul D Pharoah, Sambasivarao Damaraju, John Mackey, Kelly Hoon, Timothy Harkins, Vasisht Tadigotla, Mahvash Sigaroudinia, Philippe Gascard, Thea Tlsty, Joseph F Costello, Irmtraud M Meyer, Connie J Eaves, Wyeth W Wasserman, Steven Jones, David Huntsman, Martin Hirst, Carlos Caldas, Marco A Marra, Samuel Aparicio, None, The clonal and mutational evolution spectrum of primary triple-negative breast cancers Nature. ,vol. 486, pp. 395- 399 ,(2012) , 10.1038/NATURE10933

Miguel Martín, Aleix Prat, Álvaro Rodríguez-Lescure, Rosalía Caballero, Mark T. W. Ebbert, Blanca Munárriz, Manuel Ruiz-Borrego, Roy R. L. Bastien, Carmen Crespo, Carole Davis, César A. Rodríguez, José M. López-Vega, Vicente Furió, Ana M. García, Maribel Casas, Matthew J. Ellis, Donald A. Berry, Brandelyn N. Pitcher, Lyndsay Harris, Amparo Ruiz, Eric Winer, Clifford Hudis, Inge J. Stijleman, David P. Tuck, Eva Carrasco, Charles M. Perou, Philip S. Bernard, PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer Breast Cancer Research and Treatment. ,vol. 138, pp. 457- 466 ,(2013) , 10.1007/S10549-013-2416-2

Judith-Anne W Chapman, Torsten O Nielsen, Matthew J Ellis, Phillip Bernard, Stephen Chia, Karen A Gelmon, Kathleen I Pritchard, Aurelie Le Maitre, Paul E Goss, Samuel Leung, Lois E Shepherd, Vivien H C Bramwell, Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort Breast Cancer Research. ,vol. 15, pp. 1- 13 ,(2013) , 10.1186/BCR3465

Charles M. Perou, Therese Sørlie, Michael B. Eisen, Matt van de Rijn, Stefanie S. Jeffrey, Christian A. Rees, Jonathan R. Pollack, Douglas T. Ross, Hilde Johnsen, Lars A. Akslen, Øystein Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley X. Zhu, Per E. Lønning, Anne-Lise Børresen-Dale, Patrick O. Brown, David Botstein, Molecular portraits of human breast tumours Nature. ,vol. 406, pp. 747- 752 ,(2000) , 10.1038/35021093

Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John MS Bartlett, Michael Bilous, Patrick Fitzgibbons, Wedad Hanna, Robert B Jenkins, Pamela B Mangu, Soonmyung Paik, Edith A Perez, Michael F Press, Patricia A Spears, Gail H Vance, Giuseppe Viale, Daniel F Hayes, None, Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Journal of Clinical Oncology. ,vol. 31, pp. 3997- 4013 ,(2013) , 10.1200/JCO.2013.50.9984

Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park, William Hiller, Edwin R Fisher, D Lawrence Wickerham, John Bryant, Norman Wolmark, None, A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer The New England Journal of Medicine. ,vol. 351, pp. 2817- 2826 ,(2004) , 10.1056/NEJMOA041588

Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou, Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Breast Cancer Research. ,vol. 12, pp. 1- 18 ,(2010) , 10.1186/BCR2635

Yoav Benjamini, Yosef Hochberg, Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Journal of the Royal Statistical Society: Series B (Methodological). ,vol. 57, pp. 289- 300 ,(1995) , 10.1111/J.2517-6161.1995.TB02031.X

Lois E. Shepherd, Shan Jiang, Tammi Vickery, Elaine Mardis, Samuel Leung, Karen Ung, Kathleen I. Pritchard, Joel S. Parker, Philip S. Bernard, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen, Stephen K. Chia, Vivien H. Bramwell, Dongsheng Tu, A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen Clinical Cancer Research. ,vol. 18, pp. 4465- 4472 ,(2012) , 10.1158/1078-0432.CCR-12-0286